Last reviewed · How we verify

Ivermectin + colchicine — Competitive Intelligence Brief

Ivermectin + colchicine (Ivermectin + colchicine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiparasitic + anti-inflammatory combination. Area: Infectious disease / Immunology.

marketed Antiparasitic + anti-inflammatory combination Glutamate-gated chloride channels (ivermectin); tubulin/microtubules (colchicine) Infectious disease / Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Ivermectin + colchicine (Ivermectin + colchicine) — Ain Shams University. This combination uses ivermectin's antiparasitic and anti-inflammatory properties alongside colchicine's anti-inflammatory effects to reduce inflammation and parasitic burden.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ivermectin + colchicine TARGET Ivermectin + colchicine Ain Shams University marketed Antiparasitic + anti-inflammatory combination Glutamate-gated chloride channels (ivermectin); tubulin/microtubules (colchicine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiparasitic + anti-inflammatory combination class)

  1. Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ivermectin + colchicine — Competitive Intelligence Brief. https://druglandscape.com/ci/ivermectin-colchicine. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: